GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CAS Medical Systems Inc (NAS:CASM) » Definitions » Sloan Ratio %

CAS Medical Systems (CAS Medical Systems) Sloan Ratio % : -22.72% (As of Dec. 2018)


View and export this data going back to 1995. Start your Free Trial

What is CAS Medical Systems Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

CAS Medical Systems's Sloan Ratio for the quarter that ended in Dec. 2018 was -22.72%.

As of Dec. 2018, CAS Medical Systems has a Sloan Ratio of -22.72%, indicating there is a warning stage of accrual build up.


CAS Medical Systems Sloan Ratio % Historical Data

The historical data trend for CAS Medical Systems's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CAS Medical Systems Sloan Ratio % Chart

CAS Medical Systems Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.74 -15.91 -6.64 -20.93 -22.72

CAS Medical Systems Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.94 -23.72 -20.24 -20.01 -22.72

Competitive Comparison of CAS Medical Systems's Sloan Ratio %

For the Medical Instruments & Supplies subindustry, CAS Medical Systems's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CAS Medical Systems's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CAS Medical Systems's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where CAS Medical Systems's Sloan Ratio % falls into.



CAS Medical Systems Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

CAS Medical Systems's Sloan Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2018 )-Cash Flow from Operations (A: Dec. 2018 )
-Cash Flow from Investing (A: Dec. 2018 ))/Total Assets (A: Dec. 2018 )
=(-5.961--2.633
--0.863)/10.85
=-22.72%

CAS Medical Systems's Sloan Ratio for the quarter that ended in Dec. 2018 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2018 )
=(-5.961--2.632
--0.864)/10.85
=-22.72%

CAS Medical Systems's Net Income for the trailing twelve months (TTM) ended in Dec. 2018 was -1.418 (Mar. 2018 ) + -1.715 (Jun. 2018 ) + -1.283 (Sep. 2018 ) + -1.545 (Dec. 2018 ) = $-5.96 Mil.
CAS Medical Systems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2018 was -0.12 (Mar. 2018 ) + -1.06 (Jun. 2018 ) + -1.179 (Sep. 2018 ) + -0.273 (Dec. 2018 ) = $-2.63 Mil.
CAS Medical Systems's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2018 was -0.218 (Mar. 2018 ) + -0.26 (Jun. 2018 ) + -0.147 (Sep. 2018 ) + -0.239 (Dec. 2018 ) = $-0.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CAS Medical Systems  (NAS:CASM) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2018, CAS Medical Systems has a Sloan Ratio of -22.72%, indicating there is a warning stage of accrual build up.


CAS Medical Systems Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of CAS Medical Systems's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


CAS Medical Systems (CAS Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
44 East Industrial Road, Branford, CT, USA, 06405
CAS Medical Systems Inc is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products. The company's products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. .
Executives
Alan Milinazzo director C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078
Thomas M Patton director, officer: President and CEO C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Kenneth R Weisshaar director 875 PARK AVE APT 2D, NEW YORK NY 10021
James E Thomas director, 10 percent owner WOODS END ROAD, NEW CANAAN CT 06840
Thomas, Mcnerney & Partners Ii L.p. 10 percent owner 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402
Tmp Associates Ii Lp 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Tmp Nominee Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Thomas, Mcnerney & Partners Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Acuta Capital Fund, Lp 10 percent owner 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations International Master Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Lawrence Burstein director C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016